Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com


All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
© Image: Bundesministerium für Gesundheit (BMG)

Monday, May 26, 2025

Germany invests €10 million in WHO – Boost for Pandemic Agreement

Germany once again underlines its role as a driving force in global health policy. Federal Health Minister Nina Warken announced an additional €10 million in funding for the World Health Organization (WHO) on the eve of the World Health Assembly (WHA) following a meeting with WHO Director-General Dr. Tedros Adhanom Ghebreyesus in Geneva.

The funding aims to support internal reforms within the WHO, which gained urgency following the temporary withdrawal of the United States from the organization. Germany had already contributed €2 million in April. In total, Germany’s contributions to the WHO for 2024/2025 amount to USD 323 million.

A central item on the WHA agenda, taking place from May 19 to 27, 2025, is the international pandemic agreement, which is expected to be adopted through a resolution early next week. The agreement seeks to establish binding international cooperation on pandemic prevention, preparedness, and response.

Minister Warken emphasized: “The upcoming adoption of the international pandemic agreement shows what WHO member states are capable of: protecting people’s health worldwide through stronger cooperation.”

WHO Director-General Dr. Tedros expressed his gratitude: “I thank Germany for its sustained trust and commitment to global health […] With Germany as a partner, we will continue to support countries, protect communities, and build a stronger, better-prepared global health system for the future.”

Key elements of the pandemic agreement:

  1. Prevention & One Health Principle:
    For the first time, an international treaty recognizes the interconnection of human, animal, and environmental health. Enhanced surveillance, lab safety, and protection for healthcare workers are among the priorities.
  2. PABS – Pathogen Access and Benefit-Sharing:
    Pathogens and related data will be shared to facilitate medicine and vaccine development. In return, pharmaceutical companies will donate 10% of their production and sell up to another 10% at reduced prices, particularly for low-income countries.
  3. Technology Transfer:
    Technology transfer will be encouraged on a voluntary basis, balancing innovation and competitiveness.
  4. Sovereignty:
    The agreement respects the sovereignty of member states, clearly stating that decisions on responses to health crises remain the responsibility of individual nations.

Through this initiative, Germany is not only supporting WHO reforms but also sending a strong signal for international solidarity and global health equity.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder

Copyright 2026 Pharma-Marketing.com.